Irish firm Automsoft wins big contract with US giant
AUTOMSOFT, the Irish software company chaired by former Elan boss Donal Geaney, has been awarded a "multimillion" contract by Genzyme Corporation.
The US biotech giant will roll-out the Irish company's advanced database software called RAPID-pharma across a number of its primary therapeutic manufacturing facilities. RAPID-pharma will allow the multinational track and analyse its manufacturing process in real-time as well as complying with Federal Drug Authority guidelines.
Philip Maderia, an associate director with Genzyme, said: "RAPID-Pharma will help us optimise our processes and create consistency while minimising losses".
Automsoft, which has its development facilities in Dublin, does most of its business in North America, where it works with companies in the pharmaceutical, biotechnology, natural resources and food sectors.
Paraic O'Toole, chief executive of Automsoft, said the company had received ?6m in its latest funding round last year which it had invested in building up its sales and marketing ability.
He said the company had also recently attracted a number of high-calibre staff, including Mr Geaney who he described as playing a "transformational" role in the company. Last month, Mr Geaney also emerged as chairman of Clinical Grid.